A detailed history of Css LLC transactions in Amgen Inc stock. As of the latest transaction made, Css LLC holds 1,100 shares of AMGN stock, worth $351,538. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,100
Previous 1,700 35.29%
Holding current value
$351,538
Previous $483,000 28.99%
% of portfolio
0.03%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $157,650 - $191,586
-600 Reduced 35.29%
1,100 $343,000
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $107,548 - $129,824
400 Added 30.77%
1,700 $483,000
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $102,280 - $115,383
-400 Reduced 23.53%
1,300 $374,000
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $174,920 - $217,167
-800 Reduced 32.0%
1,700 $456,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $321,405 - $380,055
1,500 Added 150.0%
2,500 $555,000
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $225,790 - $275,200
1,000 New
1,000 $241,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $346,065 - $385,110
-1,500 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $11,182 - $12,371
-51 Reduced 3.29%
1,500 $363,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $308,462 - $353,007
1,551 New
1,551 $348,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $1.1 Million - $1.22 Million
-4,707 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $1.04 Million - $1.22 Million
4,707 New
4,707 $1.17 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $514,306 - $631,124
-2,600 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $36,448 - $48,340
200 Added 8.33%
2,600 $527,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $454,104 - $583,680
2,400 New
2,400 $579,000
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $2.37 Million - $2.67 Million
-14,295 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $2.42 Million - $2.83 Million
14,295 New
14,295 $2.44 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.